Association between blood pressure and predictive risk factors of hypertension
https://doi.org/10.18705/1607-419X-2025-2461
EDN: NGXJFM
Abstract
Objective. This study aims to analyze the characteristics of hypertension among individuals undergoing health examinations at Al-Sader Medical City in Najaf. We seek to determine potential predictors that contribute to the development and progression of hypertension. Design and methods. The study population was selected based on individuals undergoing routine health examinations from Al-Sader Medical City in Kufa city, Najaf, south of Iraq, within the period between April to October 2023. The collected data included information on age, gender, body mass index, blood lipids, blood glucose levels, and hypertension classification indices. Statistical analysis included descriptive statistics, normality testing, t-test, one-way analysis of variance (ANOVA), post hoc analysis, chi-square test. Results. A total of 334 individuals participated in the study (192 males and 142 females). The average age of the participants was 46,04 ± 14,958 years, ranging from 20 to 94 years. Among them, 118 people (35,3 %) had a family history of hypertension, and 59 people (17,7 %) had a history of smoking. Notably, female participants exhibited a higher rate of abnormal cholesterol, triglycerides (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels compared to males, particularly in the age group of 50 to 59 years. The mean levels of cholesterol, LDL, and fasting blood glucose were higher in females compared to males (p < 0,05). Furthermore, the levels of cholesterol, fasting glucose, TG, LDL, and other indicators demonstrated a significant increase with the progression of hypertension grades (p < 0,05). Conclusion. The study showed that factors such as age, gender, body mass index, blood glucose levels, blood cholesterol levels (including TG and LDL), and the presence of diabetes are closely associated with hypertension. These factors play a significant role in understanding and addressing the prevalence and management of hypertension within the examined population.
About the Author
N. A. Mohsin
Al-Furat Al-Awsat Technical University (ATU)
Iraq
Iraq
Noora Ali Mohsin, MD, The Technical Administrative College
References
1. Perger E, Baillieul S, Esteve F, Pichon A, Bilo G, Soranna D, et al. Nocturnal hypoxemia, blood pressure, vascular status and chronic mountain sickness in the highest city in the world. Ann Medi. 2022;54(1):1884–1893. https://doi.org/10.1080/07853890.2022.2091791
2. Peña-Jorquera H, Cid-Jofré V, Landaeta-Díaz L, PetermannRocha F, Martorell M, Zbinden-Foncea H, et al. Plant-based nutrition: exploring health benefits for atherosclerosis, chronic diseases, and metabolic syndrome — a comprehensive review. Nutrients. 2023;15(14):3244. https://doi.org/10.3390/nu15143244
3. Hawkley LC, Thisted RA, Masi CM, Cacioppo JT. Loneliness predicts increased blood pressure: 5-year crosslagged analyses in middle-aged and older adults. Psychol Aging. 2010;25(1):132. https://doi.org/10.1037/a0017805
4. Kjeldsen SE. Hypertension and cardiovascular risk: General aspects. Pharmacol Res. 2018;129:95–9. https://doi.org/10.1016/j.phrs.2017.11.003
5. Hajar R. Risk factors for coronary artery disease: historical perspectives. Heart Views. 2017;18(3):109. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17
6. Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–92. https://doi.org/10.1161/HYPERTENSIONAHA.119.14240
7. Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. In: Hypertension: from basic research to clinical practice. Vol. 2. Ed.by Md. Shahidul Islam. Springer Cham; 2017; pp. 307– 325. https://doi.org/10.1007/5584_2016_84
8. Tackling G, Borhade MB. Hypertensive heart disease. [Update: 2023 June 26]. In StatPearls [Internet]: StatPearls publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539800/
9. Matsushita K, Ballew SH, Wang AY-M, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696–707. https://doi.org/10.1038/s41581-022-00616-6
10. Teza H, Boonmanunt S, Unwanatham N, Thadanipon K, Limpijankit T, Pattanaprateep O, et al. Evaluation of transitions from early hypertension to hypertensive chronic kidney disease, coronary artery disease, stroke and mortality: a Thai real-world data cohort. Front Cardiovasc Med. 2023;10:1170010. https://doi.org/10.3389/fcvm.2023.1170010
11. Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, et al. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023;15(9):1– 14. https://doi.org/10.7759/cureus.45835
12. George C, Echouffo-Tcheugui JB, Jaar BG, Okpechi IG, Kengne AP. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low-and middleincome countries — a review of the current literature. BMC Med. 2022;20(1):1–12. https://doi.org/10.1186/s12916-022-02438-6
13. Dubois M-J, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27:1297–1304. https://doi.org/10.1007/s001340101017
14. Freudenberg-Hua Y, Li W, Davies P. The role of genetics in advancing precision medicine for Alzheimer’s disease — a narrative review. Front Med. 2018;5:108. https://doi.org/10.3389/fmed.2018.00108
15. Blighe K, Gurudas S, Lee Y, Sivaprasad S. Diabetic retinopathy environment-wide association study (EWAS) in NHANES 2005–2008. J Clin Med. 2020;9(11):3643. https://doi.org/10.3390/jcm9113643
16. Daly AA, Rolph R, Cutress RI, Copson ER. A review of modifiable risk factors in young women for the prevention of breast cancer. Breast Cancer. 2021:241–257. https://doi/full/10.2147/BCTT.S268401
17. Nunes HEG, Gonçalves ECdA, Vieira JAJ, Silva DAS. Clustering of risk factors for non-communicable diseases among adolescents from southern Brazil. PloS One. 2016;11(7):e0159037. https://doi.org/10.1371/journal.pone.0159037
18. Noble N, Paul C, Turon H, Oldmeadow C. Which modifiable health risk behaviours are related? A systematic review of the clustering of Smoking, Nutrition, Alcohol and Physical activity (‘SNAP’) health risk factors. Prev Мed. 2015;81:16–41. https://doi.org/10.1016/j.ypmed.2015.07.003
19. Derouiche S, Cheradid T, Guessoum M. Heavy metals, oxidative stress and inflammation in pathophysiology of chronic kidney disease-a review. AJPTech. 2020;10(3):202–6. http://dx.doi. org/10.5958/2231-5713.2020.00033.1
20. Kucia AM, Hartley A. Risk factors for cardiovascular disease. Chapter 5. In: Cardiac care: a practical guide for nurses. Second edition. Ed. by Angela M. Kucia IDJ. John Wiley & Sons Ltd.; 2022. pp. 35–51. https://doi.org/10.1002/9781119117810.ch5
21. Roy S, Schweiker-Kahn O, Jafry B, Masel-Miller R, Raju RS, O’Neill LMO, et al. Risk factors and comorbidities associated with diabetic kidney disease. J Prim Care Amp Community Health. 2021;12:1–10. https://doi.org/10.1177/21501327211048556
22. Wamala JF, Karyabakabo Z, Ndungutse D, Guwatudde D. Prevalence factors associated with hypertension in Rukungiri district, Uganda-a community-based study. Afr Health Sci. 2009;9(3):60–153. https://www.ajol.info/index.php/ahs/article/view/48999
23. Tayefi M, Shabani N, Saberi-Karimian M, Oladi M, Mouhebati M, Farjami Z, et al. Systolic and diastolic blood pressure percentiles by age and gender in Northeastern Iran. J Am Soc Hypertens. 2018;12(12):e85-e91. https://doi.org/10.1016/j.jash.2018.11.003
24. Shah S. Common terminology criteria for adverse events. National Cancer Institute: USA. 2022; pp. 784–785.
25. WHO technical specifications for automated non-invasive blood pressure measuring devices with cuff. World Health Organization; 2020.
26. Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. http://dx.doi.org/10.1016/S0140–6736(03)15268-3
27. Guidelines for the management of dyslipidaemia in patients with diabetes mellitus: quick reference guide. World Health Organization; 2006.
28. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–9. https://doi.org/10.1016/S0140-6736(12)60861-7
29. Zhou M, Offer A, Yang G, Smith M, Hui G, Whitlock G, et al. Body mass index, blood pressure, and mortality from stroke: a nationally representative prospective study of 212 000 Chinese men. Stroke. 2008;39(3):753–759. https://doi.org/10.1161/STROKEAHA.107.495374
30. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344– 2356. https://doi.org/10.1161/CIRCULATIONAHA.117.032380
31. Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, et al. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes care. 2008;31(6):1132–1137. https://doi.org/10.2337/dc07-0797
32. Almutairi AH, Almutairi NS, Mousa N, Elsayed A, El-Sehrawy A, Elmetwalli A. Aerobic exercise as a non-pharmacological intervention for improving metabolic and hemodynamic profiles in type 2 diabetes. Irish Journal of Medical Science. 2024:1– 10. https://doi.org/10.1007/s11845-024-03783-6
33. Qiao S, Ye Q, Dou Y, Li M, Kou Y, Qian D, et al. Analysis for hypertension and related risk factors of physical examination population. Int J Clin Exp Med. 2013;6(9):785–793. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798214/
34. Chen M–M, Huang X, Xu C, Song X-H, Liu Y-M, Yao D, et al. High remnant cholesterol level potentiates the development of hypertension. Front Endocrinol. 2022;13:830347. https://doi.org/10.3389/fendo.2022.830347
35. Simonova G, Mustafina S, Rymar O, Malyutina C, Sherbakova L, Kashirina A, et al. Association of non-high-density lipoprotein hypercholesterol with metabolic syndrome, diabetes and arterial hypertension in the population of 45–69 years adults. Arterial’naya Gipertenziya = Arterial Hypertension. 2022;28(5):501–17. https://doi.org/10.18705/1607-419X-202228-5-501-517
36. Leggio M, Lombardi M, Caldarone E, Severi P, D’emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40(12):947–963. https://doi.org/10.1038/hr.2017.75
37. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. https://doi.org/10.1038/s41581-019-0244-2
38. Chumakova G, Kuznetsova TY, Druzhilov M, Veselovskaya N. Obesity induced hypertension: The main pathophysiological mechanisms. Arterial’naya Gipertenziya = Arterial Hypertension. 2021;27(3):260–8. https://doi.org/10.18705/1607419X-2021-27-3-260-268
39. Kwan TW, Wong SS, Hong Y, Kanaya AM, Khan SS, Hayman LL, et al. Epidemiology of diabetes and atherosclerotic cardiovascular disease among Asian American adults: implications, management, and future directions: a scientific statement from the American Heart Association. Circulation. 2023;148(1):74–94. https://doi.org/10.1161/CIR.0000000000001145
40. Al Moraie NMD. Dietary patterns in Saudi Arabian adults residing in different geographical locations in Saudi Arabia and in the UK in relation to heart disease risk [dissertation]. Newcastle upon Tyne: Newcastle University; 2014 [cited 2024 Oct 15]. Available from: http://hdl.handle.net/10443/2562
41. Cooper JL. Health behaviour in a cultural context: a qualitative study of the impact culture and lifestyle has on the management of type 2 diabetes mellitus among UAE Nationals [dissertation]. Curtin University; 2017 [cited 2024 Oct 17]. Available from: http://hdl.handle.net/20.500.11937/57424
Review
For citations:
Mohsin N.A. Association between blood pressure and predictive risk factors of hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2025;31(4):366-375. https://doi.org/10.18705/1607-419X-2025-2461. EDN: NGXJFM
Views:
118
Email this article 